HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help

New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves

Learn More
Market News Stocks News ETF News Crypto News

Silo Pharma, Inc.

Contributing Author

Recent Articles by Silo Pharma, Inc.

Oct-06
Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci) SILO GlobeNewswire
Oct-01
Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules SILO GlobeNewswire
Sep-30
Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules SILO GlobeNewswire
Sep-29
Silo Pharma Updates Strategic Agreement with Fireblocks to Secure Crypto Treasury Management SILO GlobeNewswire
Sep-23
Silo Pharma Signs Strategic Agreement with Fireblocks to Advance Crypto Treasury Strategy Acquisition and Security SILO GlobeNewswire
Sep-16
Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy SILO GlobeNewswire
Sep-09
Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug SILO GlobeNewswire
Sep-03
Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio SILO GlobeNewswire
Aug-21
Silo Pharma's Alzheimer's Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal SILO GlobeNewswire
Aug-19
Silo Pharma's PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway SILO GlobeNewswire
Aug-05
Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform SILO GlobeNewswire
Jul-16
Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15 SILO GlobeNewswire
Jul-07
Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025 SILO GlobeNewswire
Jun-25
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market SILO GlobeNewswire
Jun-11
Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears SILO GlobeNewswire
Jun-05
Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset SILO GlobeNewswire
May-21
Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15 SILO GlobeNewswire
May-16
Silo Pharma Announces Closing of $2 Million Public Offering SILO GlobeNewswire
May-15
Silo Pharma Announces Pricing of $2 Million Public Offering SILO GlobeNewswire
May-14
Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15 SILO GlobeNewswire
May-14
Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories SILO GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.